Martin Shkreli Is Back With a Web3 Drug Discovery Platform
by Beth Mole, Ars Technica from on (#61X4T)
Just out of prison, the former executive is launching a crypto-backed venture that tests the limits of his lifetime ban from the pharmaceutical industry.